House passes final opioid package 

Sep 28, 2018 - 03:01 PM
opioids

The House of Representatives today passed by a vote of 393-8 the final version of the Opioid Crisis Response Act (H.R. 6). The House-Senate agreement includes an AHA-supported provision that would allow states to receive federal Medicaid matching funds for up to 30 days per year for services provided to adults aged 21-64 for substance use disorders in Institutions for Mental Diseases. The bill also includes AHA-supported provisions addressing health insurance for former foster youth; maternal and infant health; access to telehealth and medication-assisted treatment; parity in Children’s Health Insurance Program mental health and substance use disorder benefits; a demonstration program to promote alternatives to opioids in emergency departments; revisions to the Hospital Consumer Assessment of Healthcare Providers and Systems questions relating to pain management; care coordination for drug overdose patients; and improvements to coordination of prescription drug monitoring programs. The Senate is expected to vote on the agreement in October.
 

Related News Articles

Headline
AHA wins 2 Telly Awards for behavioral health video series
 The AHA has won two Telly Awards for its three-part video series, Voices of Leadership: Breaking Mental Health Stigma. The Telly Awards, a global…
Headline
AHA podcast: Reducing Stigma in Substance Use Disorder Care 
In this conversation, three leaders from CommonSpirit Health explore how the organization is confronting stigma about substance use head-on through education,…
Headline
HRSA to award grants from two areas of rural opioid response program
The Health Resources and Services Administration will award grants to rural hospitals and other providers from two areas of its Rural Communities Opioid…
Perspective
Behavioral Health Is Health Care
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…
Headline
FDA fast-tracks the development of psychedelic medications following president’s executive order
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…
Headline
Data highlights gaps in finding in-network mental health coverage 
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…